Sumatriptan Succinate Tablets SPE2D223R0003
Summary
AI-generated · Aug 24, 2025Option Year Two for Sumatriptan Succinate Tablets is being exercised, extending the current contract for a one-year period to continue delivery of the product. The modification SPE2D223D0009 P00002 implements the extension and awards the option year to Golden State Medical Supply Inc for approximately $14,927,157.36.
Modification SPE2D223D0009 P00002 posted to announce exercising of Option Year Two (2), effective July 25, 2025 through July 24, 2026.
From Award Notice posted on Jul 03, 2025Notice history
1Details
Award Information
Award Notices
Posted: Jul 03, 2025
Modification SPE2D223D0009 P00002 posted to announce exercising of Option Year Two (2), effective July 25, 2025 through July 24, 2026.
Awardees
| Company Name | UEI | CAGE Code | Location |
|---|---|---|---|
| GOLDEN STATE MEDICAL SUPPLY INC | GQLDJJ8AQNN5 | 1HT23 | Camarillo, CA |
Contacts
Phone
Phone
Agency
Place of Performance
AUS